Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?

Bone Marrow Transplantation
E JabbourIssa Khouri

Abstract

Novel therapeutic approaches with conventional chemotherapy and monoclonal antibody combinations have improved the complete remission rates in chronic lymphocytic leukemia. However, cure remains elusive, particularly in fludarabine-refractory patients, whose prognosis remains poor. Autologous stem cell transplantation (SCT) has been explored for such patients, lengthening the time to treatment failure in selected patients, but there is little hope that it will improve the cure rate. The strategy is particularly ineffective in patients with poor biological prognostic factors, such as abnormal cytogenetics and unmutated immunoglobulin heavy-chain variable region. Allogeneic SCT remains the only curative approach, producing an extended disease-free survival in 25-60%, mainly via the graft-versus-leukemia effect. The treatment-related mortality with such an approach has been significant, however, with a 30-40% risk of death within 100 days of the transplant. Nonmyeloablative (NMA) conditioning regimens may produce high response rates and lower morbidity, especially for patients with chemosensitive disease. Randomized trials designed according to the new biologic prognostic parameters described in chronic lymphocytic leukemia are re...Continue Reading

References

Oct 19, 1995·The New England Journal of Medicine·C Rozman, E Montserrat
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F KhouriS A Giralt
Jun 1, 1997·British Journal of Haematology·M J DyerD Catovsky
Nov 14, 1998·Current Opinion in Hematology·I F KhouriR Champlin
Feb 19, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·J L SchultzeJ G Gribben
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Caligaris-Cappio, T J Hamblin
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage
Apr 4, 2000·Bone Marrow Transplantation·Z S PavleticM R Bishop
Oct 29, 2000·British Journal of Haematology·J RodriguezI F Khouri
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Jun 16, 2001·The New England Journal of Medicine·M J LaughlinJ Kurtzberg
Mar 13, 2002·Clinical Pharmacokinetics·Varsha Gandhi, William Plunkett
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·Leanne BerkahnHans-Georg Klingemann
May 9, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HosingI F Khouri
Jun 12, 2002·Bone Marrow Transplantation·K C DoneyUNKNOWN Seattle Bone Marrow Transplant Team
Apr 19, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HosingI F Khouri
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ScheteligUNKNOWN Cooperative German Transplant Study Group
Jan 17, 2004·Lancet·Jenny A OrchardDavid G Oscier
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maricer P EscalónIssa F Khouri

❮ Previous
Next ❯

Citations

Jan 27, 2009·Current Treatment Options in Oncology·Tahamtan AhmadiEdward Stadtmauer
May 17, 2005·Bone Marrow Transplantation·B W Butcher, R H Collins
Feb 17, 2007·Critical Reviews in Oncology/hematology·Michael Y ShapiraS Slavin
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol MorenoEmili Montserrat
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorDavid G Maloney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

© 2022 Meta ULC. All rights reserved